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N,N-Bis-(dimethylﬂuorosilylmethyl)amides of N-
organosulfonylproline and sarcosine: synthesis,
structure, stereodynamic behaviour and in silico
studies†
Alexey A. Nikolin,*a Eugenia P. Kramarova,a Alexander G. Shipov,a Yuri I. Baukov,a
Vadim V. Negrebetsky,a Dmitry E. Arkhipov,b Alexander A. Korlyukov,b
Alexey A. Lagunin,cd Sergey Yu. Bylikin,e Alan R. Bassindalee and Peter G. Taylore
(O/Si)-Chelate diﬂuorides R3R2NCH(R1)C(O)N(CH2SiMe2F)2 (9a–c, R1R2 ¼ (CH2)3, R3 ¼ Ms (a), Ts (b); R1 ¼
H, R2 ¼Me, R3 ¼Ms (c)), containing one penta- and one tetracoordinate silicon atoms were synthesized by
silylmethylation of amides R3R2NCH(R1)C(O)NH2, subsequent hydrolysis of unstable intermediates
R3R2NCH(R1)C(O)N(CH2SiMe2Cl)2 (7a–c) into 4-acyl-2,6-disilamorpholines R3R2NCH(R1)C(O)
N(CH2SiMe2O)2 (8a–c) and the reaction of the latter compounds with BF3$Et2O. The structures of
disilamorpholines 8a,c and diﬂuoride 9a were conﬁrmed by an X-ray diﬀraction study. According to the
IR and NMR data, the O/Si coordination in solutions of these compounds was weaker than that in the
solid state due to eﬀective solvation of the Si–F bond. A permutational isomerisation involving an
exchange of equatorial Me groups at the pentacoordinate Si atom in complexes 9a–c was detected, and
its activational parameters were determined by 1H DNMR. In silico estimation of possible
pharmacological eﬀects and acute rat toxicity by PASS Online and GUSAR Online services showed
a potential for their further pharmacological study.
Introduction
Hypercoordinate silicon compounds are the focus of intense
research due to the diversity of their structures, chemical
properties,1 stereodynamic behaviour2 and practical use in
stereoselective synthesis3 and medical diagnostics.4 In recent
years a large number of new types of pentacoordinate silicon
compounds have been synthesized, including complexes with
ve diﬀerent atoms in the silicon environment, compounds
with SiO5, SiS2N2C, SiS2O2C, SiN4X (X ¼ S, Se, Te) skeletons and
others.5
At the same time, certain classes of organosilanes containing
both penta- and tetracoordinate silicon atoms in the same
molecule remain virtually unknown. Among these compounds
are N,N-bis(dimethylhalogenosilylmethyl)amides, where two
silicon centres compete for a single carbonyl group. One of the
Si atoms in these amides extends its coordination number to
ve and forms an (O/Si)-chelate ring while another Si atom
remains tetracoordinate. Up to date, very few examples of such
compounds have been reported,6 with the structures of only
four complexes (1,6b 2,6b 3 (ref. 6e) and 4 (ref. 6e)) determined by
X-ray method.
Since each of the two silicon atoms in dihalides 1–4 can
potentially form a coordination bond with the carbonyl group,
these compounds are particularly interesting as models for
studying stereodynamic processes in solutions (such as alter-
nating coordination or permutational isomerisation), pathways
of SN2–Si reactions, relative contributions of the silicon centres
to O/Si coordination and the eﬀects of such coordination on
the reactivity of SiIVMe2Hal and Si
VMe2Hal groups within
a single molecule.
Earlier we described (O/Si)-monochelate uorosilanes RSO2-
Pro-N(Me)CH2SiMe2F (5), containing an electron-withdrawing
organosulfonyl group at the nitrogen atom of the amino acid
fragment.7 In the present work, we report the synthesis, structures
and stereodynamic behaviour of dinuclear uorosilyl derivatives
of proline and sarcosine R3R2NCH(R1)C(O)N(CH2SiMe2F)2 (9),
synthesised by bis-silylmethylation ofN-organosulfonyl-(S)-proline
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and N-mesylsarcosine amides R3R2NCH(R1)C(O)NH2 (6) via
unstable dichlorides R3R2NCH(R1)C(O)N(CH2SiMe2Cl)2 (7) and
isolable N-substituted 2,6-disilamorpholines R3R2NCH(R1)C(O)
N(CH2SiMe2O)2 (8).
Discussion of the results
Synthesis of disilamorpholines
Disilamorpholines 8 were prepared by the general synthetic
approach developed by us for various silacyclanes.6d,e,8 The
starting compounds, primary amides 6, were silylmethylated by
a mixture of chloro(chloromethyl)dimethylsilane and hexame-
thyldisilazane with subsequent hydrolysis of unstable dichlor-
ides 7 into target 4-acyl-2,6-disilamorpholines 8 (Scheme 1).
Mesyl and tosyl derivatives of (S)-proline, Ms-Pro-N(CH2-
SiMe2)2O (8a) and Ts-Pro-N(CH2SiMe2)2O (8b), and mesyl
derivative of sarcosine, MsN(Me)CH2C(O)N(CH2SiMe2)2O (8c),
were obtained by one-pot syntheses with yields of 75, 78 and
80%, respectively. The composition and structures of
compounds 8 were conrmed by the elemental analysis, IR and
multinuclear (1H, 13C, 29Si and CP/MAS 29Si) NMR spectroscopy.
The structures of compounds 8a and 8cwere also determined by
X-ray method (see below).
The formation of hydrolytically unstable dichloride 7a was
detected by IR spectroscopy. When a mixture of amide 6a with
three equivalents of ClCH2SiMe2Cl and one equivalent of
(Me3Si)2NH was reuxed in benzene or toluene, the absorption
of the NCO fragment in 6a was gradually replaced by two
absorptions (at 1590 and 1505 cm1) of the same fragment in
7a, which was typical O/Si chelates of pentacoordinate sili-
con.6b,9 IR spectra of all 4-acyl-2,6-disilamorpholines 8a–c
showed a strong absorption of the NCO fragment at 1630 cm1.
In the 1H NMR spectra of chiral proline derivatives 8a,b, the
signals of two SiMe2 groups appear as four singlets.
The 29Si NMR spectra of disilamorpholines 8a–c in solutions
contain two signals at approximately 8 and 10 ppm, which are
almost independent of the amino acid or N-substituent nature.
The same chemical shis of 29Si are observed in the solid-state
CP/MAS spectra of these compounds (see Experimental
section). Therefore, the solvation of tetracoordinate silicon
atoms has no noticeable eﬀect on their chemical shis.
The above data suggest that both silicon atoms in
compounds 8a–c are tetracoordinate.6c Similar to the double set
of signals of SiMe2 groups in
1H NMR spectra, the presence of
two signals in 29Si NMR spectra of these compounds is probably
caused by the hindered amide rotation.
Synthesis of diuorides
In contrast to hydrolytically labile Si–Cl bonds in pentacoordi-
nate dichlorides 7a–c, the Si–F bonds in their diuoro
analogues 9a–c were expected to be more stable. (O/Si)-
Chelate N0,N0-bis(dimethyluorosilylmethyl)-N-organosulfonyl-
(S)-prolinamides (9a,b) and N0,N0-bis(dimethyl-
uorosilylmethyl)-N-mesylsarcosinamide (9c) were prepared by
the reaction of disilamorpholines 8a–c with BF3$Et2O in aceto-
nitrile (Scheme 2).
The composition and structure of diuorides 9a–c were
determined by the elemental analysis, IR and multinuclear (1H,
Scheme 1
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13C and 29Si) NMR spectroscopy. The coordination states of
both silicon atoms in compound 9a in the solid state was
further conrmed by X-ray single-crystal study (see below) and
29Si CP/MAS NMR.
Multinuclear NMR spectroscopy
1H NMR spectra of diuorides 9a–c contain two signals of the
SiMe2 groups in the upeld region. These signals can be
attributed to specic SiMe2 groups using Bruker 2D pulse
sequence {1H-29Si}HMBS. For example, the cross-peaks in the
2D spectrum of 9b (Fig. 1) indicate that the upeld signal of
SiMe2 protons corresponds to the signal of pentacoordinate
29Si
at 20 ppm while the downeld signal of SiMe2 protons
corresponds to the signal of tetracoordinate 29Si at +30 ppm.2b,c
Direct spin–spin coupling constants 1JSiF in NMR spectra of
compounds 9 for tetracoordinate silicon (230–260 Hz) were
generally lower than those for pentacoordinate silicon (ca. 280
Hz; see Experimental section). Such diﬀerence, observed both in
solutions and solid state, reected the weakening of the Si–F
bond at SiV in comparison with SiIV (see X-ray data for 9a).2b,c For
the same reason, the spin–spin coupling constant 3JHF was
observed at ambient temperature only for the SiIVMe2 group but
not for the SiVMe2 group. Finally, the weakening of the Si
V–F
bonds aﬀected the 2JCF constants in
13C NMR spectra: the
observed spin–spin coupling frequencies at SiV centres (10–15Hz)
were signicantly lower than those at the SiIV centres (ca. 30 Hz).
Intramolecular O/Si coordination in complexes 9 in solu-
tions was further conrmed by the down eld shi of the C]O
Scheme 2
Fig. 1 Two-dimensional NMR spectrum of 9b (Bruker {1H-29Si}HMBS, CDCl3, 600 MHz).
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 75315–75327 | 75317
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signal in their 13C NMR spectra. The characteristic patterns of
SiV(CH3)2 and NCH2Si
V signals in 1H NMR spectra of diuorides
9a,b (two singlets of equal intensity and an AB-system quartet,
respectively) indicated the presence of a chiral carbon atom in
their molecules.
The 29Si signals in solid-state NMR spectra of compounds 9
had greater upeld shis (ca. 40 ppm) than the same signals
in solutions (ca. 10 ppm). Similar eﬀect was observed for
monouorides 5 and was probably caused by eﬀective solvation
of pentacoordinate silicon.7a
Using the diﬀerence between the observed chemical shis of
a SiV atom and the typical chemical shi of a SiIV atom (ca. 30
ppm), the coordination contribution (Dd ¼ dSiV  dSiIV)2a in
diuorides 9 can be estimated to be approximately 50 ppm. The
comparison of this value to coordination contributions in
chlorosilanes RSO2-Pro-N(Me)CH2SiMe2Cl (70–75 ppm), sily-
loxonium halides [R-Pro-N(Me)CH2SiMe2OH2]X (R ¼ AlkSO2,
ArSO2, Ac; X ¼ Cl, Br) (70–80 ppm)10 and theoretical data for
monouorosilanes 5 (ref. 7b) and MeC(O)N(Me)CH2SiMe2F11
(same as above) indicates a relatively weak coordination in
diuorides 9.
All diuorides have two signals in their 19F NMR spectra: one
at approximately 159 ppm and another at 119O 125 ppm.
According to literature data, these signals belong to SiIVMe2F
and SiVMe2F groups, respectively.2b,c
Variable-temperature 1H, 19F and 29Si NMR studies
The strength of intramolecular coordination in monochelates
of pentacoordinate silicon strongly depends on the nature of
the substituent X (Scheme 3; see2c,7a and references therein).
In the case of compounds with the OSiC3X coordination set
and X ¼ Hal or OTf, structures A and B are typical for uorides,
C for chlorides, D for bromides, and E for iodides and triates.
To study the temperature eﬀects on the coordination set
structure in diuorides 9a–c, the temperature-dependent 1H,
19F and 29Si NMR spectra of these compounds in CDCl3 were
obtained. The decrease in temperature from +20 to 60 C led
to reversible downeld shis of 1H and 19F signals (by ca. 0.03
and 3–4 ppm, respectively) of the SiVMe2F group. At the same
time, the chemical shi of 19F in the SiIVMe2F group was not
aﬀected by the temperature. Such behaviour of 1H and 19F
signals suggests an increased contribution of form B (Scheme 3)
at low temperatures.
Similar to monouorosilanes,7a the increase in temperature
to +60 C caused very small reversible broadening of the SiMe2
and NCH2 signals in
1H NMR spectra of diuorides 9a–c. Such
broadening was indicative of a permutational isomerisation at
the SiV coordination set of these compounds.
The activation parameters of the permutation were calcu-
lated by a 1H DNMR method using a full line-shape analysis of
the signals. For all studied compounds, the stereodynamic
processes in CDCl3 were characterised by a narrow range of
activation energies (24 kcal mol1 or greater) and high nega-
tive values of the entropy of activation (ca.20 cal mol1 K1).
These values were very similar to the activation parameters of N-
(dimethyluorosilylmethyl)- and N-[uoro(methyl)(phenyl)silyl-
methyl]amides and -lactams,2a,12–15 as well as RSO2-Pro-N(Me)
CH2SiMe2F (5),6a where R ¼ Me, Ph, 4-MeC6H4, 4-ClC6H4, 4-
BrC6H4 or 4-NO2C6H4.
XRD studies
Disilamorpholine 8a (Fig. 2) crystallizes in two polymorph
modications (8a and 8a0).
The orthorhombic (P212121) crystals 8a were obtained from
a heptane–benzene mixture with a molar ratio of 3 : 1, whereas
Scheme 3
Fig. 2 Molecular structure of 8a with thermal ellipsoids shown at the
50% probability level.
75318 | RSC Adv., 2016, 6, 75315–75327 This journal is © The Royal Society of Chemistry 2016
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monoclinic (P21) crystals 8a0 were obtained from ethanol. There
are two crystallographically independent molecules in the
asymmetric unit of 8a; its volume is 3.84 times larger than that
of 8a0, because the cell 8a0 contains a void of about 40 A˚3. The
structure of the 2,6-disilamorpholine fragment in compounds
8a, 8a0 and 8c (Fig. 3) is analogous to the previously published
ve structures (CSD refcodes:16 QOMTAN, QOMTER, XATQIT,
XULNAT, XULNEX).
The mesyl group and 2,6-disilamorpholine fragment have
syn-conformation relative to the proline ring: the corresponding
torsion angles C8–N2–S1–C12 and C20–N4–S2–C24 in 8a are
95.3(2) and 88.8(2) for two crystallographically independent
molecules, respectively, and the torsion angle C8–N2–S1–C12 in
8a0 is 94.7(5).
An asymmetric unit of diuoride 9a contains two crystallo-
graphically independent molecules, which diﬀer by mutual
orientation of the proline moiety and Me2FSiCH2 group relative
to the chelate ring. In the case of syn-conformation, the inter-
atomic distance S1/Si2 is 5.387(1) A˚, whereas for anti-congu-
ration the distance S2/Si4 is 6.340(1) A˚. In 9a (Fig. 4), one of the
silicon atoms is pentacoordinated, and its coordination poly-
hedron is a distorted trigonal bipyramid (axial angles O1–Si1–F1
and O4–Si3–F3 are 172.1(1) and 171.9(1), the deviations of Si1
and Si3 atoms from the planes of equatorial substituents toward
uorine atoms are 0.167(1) A˚ and 0.176(1) A˚ for two crystallo-
graphically independent molecules, respectively).
The structures of coordination polyhedra of Si1 and Si2
atoms in 9a are noticeably diﬀerent from those in the series of
(O/Si)-chelate N0-(dimethyluorosilylmethyl)-N0-methyl-N-
(organosulfonyl)prolinamides,7a complexes 1 (ref. 6d) and 3 (ref.
6e) (selected bond lengths are given in Table 1).
The structure of 3 diﬀers signicantly from other diuorides
due to the coordination of amide oxygen atom with the diuoro-
boron group while the coordination with the silicon atom is very
weak. Thus, the axial Si–O bonds are shortened by 0.07–0.17 A˚,
and SiV–F bonds lengthened by 0.02–0.04 A˚ compared to similar
bonds in prolinamide derivatives and diuoride 1. The SiIV–F
bonds are lengthened by 0.05–0.10 A˚ in comparison with
similar bonds in diuorides 1 and 3. Atoms Si2 and Si4 are not
coordinated by any oxygen atoms, with the shortest intermo-
lecular contact Si4/O2 of 3.538(1) A˚.
Quantum-chemical studies of the permutational
isomerization
To test the applicability of the mechanism (Scheme 4) previ-
ously suggested for the permutational isomerisation of N-
(dimethyluorosilylmethyl)amides1 to N,N-bis-(dimethyl-
uorosilylmethyl)amides, we carried out quantum chemical
studies of molecule 9a.
At higher temperatures, the equilibrium B# A (Schemes 3
and 4) shis towards the tetracoordinate topomer A. The
nucleophilic attack at the Si atom by a uoride anion (F*)
produces pentacoordinate diuoride G, which subsequently
loses the F anion and forms tetracoordinate intermediate H.
The rotation around the Si–CH2 bond produces topomer A0 and
Fig. 3 Molecular structure of 8c with thermal ellipsoids shown at the
50% probability level.
Fig. 4 Molecular structure of 9a with thermal ellipsoids shown at the
50% probability level.
Table 1 Selected bond lengths for structures 9a, 1, 3 and prolinamide
derivatives
9a (mean values) 1 (ref. 6d) 3 (ref. 6e) Monouorides7a
SiIV–F 1.613(1) 1.603 1.608 —
SiV–F 1.693(1) 1.668 1.620 1.651–1.671
Si/O 2.062(1) 2.187 2.918 2.131–2.220
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 75315–75327 | 75319
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nally complex B0 with inverted orientation of the methyl
groups at silicon.
According to our previous study, the external uorine anion
can attack tetracoordinated silicon, and the dissociation energy
of resulting Si–F bond in gas phase is equal to 90 kcal mol1.
Solvation of the F anion leads to signicant decrease of the Si–F
dissociation energy. It is reasonable to assume that similar
processes can occur in solution of 9a in CDCl3. Due to the
presence of two dimethyluorosilylmethyl and one bulky tosyl
groups, the silicon atoms seems to be less accessible for nucle-
ophilic attack as compared to N-(dimethyluorosilylmethyl)
amides, where only one dimethyluorosilylmethyl group
is present. Hence, the stereodynamic processes in solution
of 9a can be more complex as compared to N-(dimethyl-
uorosilylmethyl)amides.7a
An alternative mechanism can involve the carbonyl group
migration from one dimethyluorosilyl to another (similarly to
derivatives urea17) (Scheme 5).
In any case, the cleavage of the Si–O coordination bond and
the certain conformational changes are necessary to the transfer
the carbonyl oxygen atom from one dimethyluorosilylmethyl to
another. Thus, the detailed inspection of these processes can be
very useful for understanding the nature of permutational iso-
merisation in the solution of 9a.
Quantum-chemical calculations of 9a were carried out using
Gaussian 03W program.18 Hybrid PBE0 functional and 6-
311G(d,p) basis set were utilized for structure optimization,
hessian calculations, relaxed potential energy scans and tran-
sition state search. To account for the eﬀect of nonspecic
solvation, the PCM model was applied (the value of dielectric
constant corresponded to chloroform). All calculations was
performed with tight optimization criteria (Opt ¼ tight) and
precise grid for computation of two-electron integrals (Int(Grid
¼ Ultrane)). Molecular graphics was drawn with ChemCra
program.19 General views of calculated structures, atomic
coordinates and total energies can be found in ESI.†
Analysis of potential energy surface for 9a in its isolated
molecule and CDCl3 (PCM calculation) has shown that the
presence of two conformational isomers correspond to the
cyclic structures (where the Si–O coordination bond is present)
and two other conformers belong are acyclic (Si–O coordination
bond is absent). According to quantum chemical calculations,
the inuence of dielectric continuum used in PCM model leads
to signicant changes in molecular structure of 9a. The most
noticeable change is the decrease of Si1/O1 distance from
2.36–2.37 to 2.25 A˚. Cyclic conformers are more favourable as
compared to the acyclic conformers. The diﬀerence between
two isolated most stable cyclic and acyclic structures is 2.51 kcal
mol1. The use of PCM model for the description of solvation
increases this diﬀerence to 4.37 kcal mol1, which is in good
agreement with our earlier calculations.7a All cyclic conformers
can be characterized by the same geometry of coordination
Scheme 4
Scheme 5
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polyhedra of silicon atoms, so their 19F and 29Si chemical shis
should be very close.
Other diﬀerences are related to mutual orientation of N-
organosulfonyl and dimethyluorosilyl groups. In isolated
cyclic and acyclic forms of 9a, these fragments are much closer
to each other than in the solution. In two conformers (9a-cyclic2
and 9a-acyclic2, Fig. 5S and 6S, see ESI†), the Si2/O2 distances
between one of the SiMe2F groups and the oxygen atom of the
sulfonyl group are 3.698 and 3.720 A˚, respectively. The optimi-
zation of these conformers in terms of PCM model (9a-cyclic2-
CDCl3 and 9a-acyclic2-CDCl3, Fig. 7S and 8S†) increases the
separation of the above fragments (the Si2/O2 distances
become 4.533 and 3.962 A˚). Conformers 9a-cyclic and 9a-acyclic
(Fig. 1S and 2S†) are stabilized by weak C–H/O bonds between
sulfonyl and methyl groups, so the Si2/O2 distances are 3.724
and 4.450 A˚. Again, the application of PCM model increases
Si2/O2 distances to 4.292 and 4.376 A˚ (9a-cyclic-CDCl3 and 9a-
acyclic-CDCl3, Fig. 3S and 4S†). Thus, the eﬀect of nonspecic
solvation prevents the formation of Si2/O2 interactions, so the
permutational isomerisation involving the sulfonyl group is
unlikely to take place.
The information about the barrier of rotation around Si1–C3
and N1–C4 bonds can be useful to understand the mechanism
of permutational isomerisation of 9a. These barriers were
calculated by the relaxed potential energy surface scan of CNCO
and F1Si1C3N1 torsion angles (the plots of the energy vs. scan
coordinate are placed in ESI (Fig. 9S and 10S†)). The value of the
rotation barrier around the Si1–C3 bond in isolated molecule 9a
is approximately 7 kcal mol1 (Fig. 9S†), so the rotation around
the Si–C bond is possible despite the presence of an Si1–O1
coordination bond. In solution, the value of this barrier is even
lower than that in isolated molecule (5.1 kcal mol1). It is not
surprising that the rotation around the N1–C4 bond is less
favourable than the rotation around the Si1–C3 bond. Firstly,
the N1–C3 bond is intermediate between ordinary and double
(Table 2). Secondly, the rotation around the N1–C3 bond is
attributed to the formation and cleavage of Si1–O1 and Si2–O1
coordination bonds. Our calculation gave the values of 26.3 kcal
mol1 for isolated molecule 9a and 24.8 kcal mol1 for its
solution in chloroform (Fig. 10S†). These values are very close to
the permutational barriers measured for 9a–c by 19F DNMR
study. Thus, the internal rotation can be responsible for the
permutational isomerisation of 9a. Additional justication for
this assumption was obtained by the localization of transition
states (Fig. 11S and 12S†). The modes of negative vibrations
(67.0 and 62.8 cm1 for isolated molecule and CDCl3 solu-
tion, respectively) correspond to the rotation around the N1–C4
bond and formation/dissociation of Si–O coordination bonds.
The diﬀerence between energies of the most favourable cyclic
conformers and transition state is 28.4 and 29.3 kcal mol1 for
isolated molecules and solution of 9a, respectively. These values
are in agreement with the results of DNMR study. At the same
time, the DS value calculated as the diﬀerence between the
transition state and cyclic isomer is 2 kcal mol1 K1, which
is much lower than the experimental value. In our opinion, this
diﬀerence can be explained by specic solvation (for instance,
H-bonds between CDCl3 and carbonyl or sulfonyl groups, which
can be responsible for stabilization of particular conformers).
In silico estimation of possible pharmacological applications
Possible applications of synthesized complexes were evaluated
by the search for similar compounds with known activities and
computational prediction of biological activity based on
“structure–activity” relationships (SAR) models. Such analysis
provides a reasonable basis for planning further experimental
studies of biological activity.
In this study, we used the PubChem structural search for
identication of equivalent and similar structures (https://
pubchem.ncbi.nlm.nih.gov).20 The similarity was assessed by
the Tanimoto equation and the PubChem dictionary-based
binary ngerprint analysis (https://pubchem.ncbi.nlm.nih.gov/
search/help_search.html). The search results for similar
compounds are shown in Table 3.
According to Table 3, the studied complexes have diﬀerent
similar compounds with variable known activities. No two
complexes have the same most similar compound, which could
indicate their similar biological potentials.
Computational prediction of biological activity for studied
complexes was carried out using SAR-based online services.
Possible therapeutic eﬀects and mechanisms of action were
evaluated by PASS Online21 (http://www.way2drug.com/
PASSOnline) while the LD50 values for acute rat toxicity were
estimated by GUSAR Online22 (http://www.way2drug.com/gusar/
acutoxpredict.html). The results of these predictions are
summarized in Table 4.
The prediction results suggest that synthesized compounds
may possess cardiovascular and CNS properties. Low levels of
predicted acute rat toxicity makes them suitable for all routes of
administration.
Conclusions
New diuorides R3R2NCH(R1)C(O)N(CH2SiMe2F)2 (9a–c) with
one pentacoordinate and one tetracoordinate silicon atoms
were synthesized by silylmethylation of amides R3R2NCH(R1)
C(O)NH2, subsequent hydrolysis of unstable intermediates
R3R2NCH(R1)C(O)N(CH2SiMe2Cl)2 (7a–c) into 4-acyl-2,6-
disilamorpholines R3R2NCH(R1)C(O)N(CH2SiMe2O)2 (8a–c)
and the reaction of the latter compounds with BF3$Et2O.
Table 2 Calculated bond distances and angles in conformers of 9a
Conformer Si1/O1 Si2/O2 Si1–F1 Si2–F2 O1Si1F1
9a-cyclic 2.368 4.450 1.665 1.632 169.20
9a-acyclic 3.130 3.724 1.638 1.646 79.69
9a-cyclic-CDCl3 2.248 4.533 1.686 1.640 170.25
9a-acyclic-CDCl3 3.222 3.962 1.652 1.644 78.82
9a-cyclic2 2.356 3.698 1.667 1.637 168.96
9a-acyclic2 2.984 3.720 1.637 1.639 76.09
9a-cyclic2-CDCl3 2.250 4.292 1.686 1.643 169.97
9a-acyclic2-CDCl3 3.175 4.376 1.644 1.644 77.90
9a-ts 4.828 3.969 1.638 1.637 112.44
9a-ts-CDCl3 4.947 3.777 1.645 1.648 115.07
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 75315–75327 | 75321
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
5/
02
/2
01
7 
15
:2
6:
57
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
According to IR and NMR data, the O/Si coordination in
solutions of these compounds was weaker than in the solid state
due to eﬀective solvation of the Si–F bond. The absence of spin–
spin coupling constants 3JHF of the methyl groups at Si
V and
their retention at SiIV indicates a signicant weakening of the
Si–F bond at pentacoordinate silicon, which favours its ioniza-
tion. Based on in silica analysis, the synthesized compounds
show a potential for pharmacological studies.
Experimental section
IR-spectra of compounds in solution and in the solid state were
recorded on a Bruker Tensor-27 spectrometer using KBr cells
and an APR element, respectively. 1H, 13C and 19F NMR spectra
in CDCl3 and DMSO-d6 were recorded on a Bruker Avance II 300
(1H, 300 MHz; 13C, 75.6 MHz; 19F, 282.2 MHz) and Jeol JNM-
EX400 (1H, 400 MHz; 13C, 100.6 MHz; 19F, 376.3 MHz) instru-
ments using standard pulse sequences. 29Si NMR spectra were
recorded using the 1H-29Si HSQC pulse sequence supplied with
the Bruker Avance II 600 instrument.23 The 1H, 13C, 29Si chem-
ical shis were measured using Me4Si as internal reference. The
19F chemical shis were measured using BF3 as external refer-
ence. Negative values are to high eld. 29Si NMR CP/MAS
spectra in the solid state were recorded on a Jeol JNM-EX-400
instrument using 5 mm zirconia rotors and a Doty probe.
The temperature calibration of the NMR spectrometers was
performed by measuring the diﬀerences in chemical shis
between non-equivalent protons in methanol (90.+30 C)
Table 3 The search results for similar compounds in PubChema
ID Hits (probability)
The most similar compound with data on
patents or activity
8a 0 (90%); 161 (80%) N-[(3S)-1-Methyl-2-oxopiperidin-3-yl]-N-(2-
oxopropyl)methanesulfonamide (CID 58869395)
Patent description: sulfonylaminovalerolactams
and derivatives thereof as factor Xa inhibitors
8b 216 (90%) 4,40-Ethylenebis(1-methyl-2,6-piperazinedione)
(CID 97592)
Patent description: novel drug targets to
overcome de novo drug-resistance in multiple
myeloma; method of reducing amyloid-beta
peptide levels using a bisdioxopiperazine;
abatement process for contaminants; bis-
dioxopiperazines and their use as protection
agents bis-dioxopiperazines and their use as
protection agents
Known activity: small molecule inhibitors of
FGF22-mediated excitatory synaptogenesis &
epilepsy measured in biochemical system using
RT-PCR – 7012-
01_Inhibitor_SinglePoint_HTS_Activity
8c 0 (90%); 19 (80%) 2-(4-Acetylpiperazin-1-yl)-N-
methylsulfonylacetamide (CID 89504348)
Patent description: dual-acting antihypertensive
agents having angiotensin II type receptor
antagonist activity and neprilysin-inhibition
activity
9a 0 (90%); 74 (80%) (1) N-(4-Amino-5-oxo-5-pyrrolidin-1-ylpentyl)
methanesulfonamide (CID 17960593)
Patent description: alpha-amino acid sulphonyl
compounds
(2) (2S)-1-[2-[Methyl(methylsulfonyl)amino]
ethyl]pyrrolidine-2-carboxamide (CID 57572120)
Patent description: quinolinone compounds as
5-HT4 receptor agonists
9b 59 (90%) Azepan-1-yl-[1-(4-methylphenyl)
sulfonylpyrrolidin-2-yl]methanone (CID
2964486)
Known activity: active in HTS assay for activators
of cytochrome P450 2A9
9c 0 (90%); 10 (80%) N,N-Dimethyl-2-[methyl(methylsulfonyl)amino]
acetamide (CID 57682568)
Patent description: HIV integrase inhibitors
a Hits – number of similar compounds ($90% or $ 80% Tanimoto index); CID – PubChem Compound ID.
75322 | RSC Adv., 2016, 6, 75315–75327 This journal is © The Royal Society of Chemistry 2016
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and ethyleneglycol (+30.+85 C).24 The activational parameters
of the permutational isomerisation were calculated using
DNMR-SIM soware25 and amodied Eyring equation.26 In each
case, at least twelve temperature points were obtained to ach-
ieve a correlation coeﬃcient of 0.997–0.999.
Chloro(chloromethyl)dimethylsilane, (S)-proline hydrochlo-
ride, sarcosine and all solvents were purchased from Acros and
Sigma-Aldrich. Ethyl esters of N-mesyl-(S)-proline and N-tosyl-
(S)-proline were synthesised as described earlier.10
Ethyl-N-mesyl-N-methylglycinate
Thionyl chloride (83.3 g, 0.27 mol) was added dropwise to
a solution of N-methylglycine (44.5 g, 0.50 mol) in absolute
ethanol (200 mL). The mixture was reuxed for 5 h, then the
volatiles were removed in vacuum. The residue was sus-
pended in an ice-cold mixture of water (20 mL) and diethyl
ether (100 mL), and a solution of potassium hydroxide (28.0 g,
0.50 mol) in water (20 mL) was added over 5 min at 0 C,
followed by 250 g of anhydrous potassium carbonate. The
organic layer was separated, the residue was washed with
ether (2  50 mL), and the combined organic solutions were
dried over magnesium sulfate. The solvent was removed in
vacuum, and the residue was distilled to aﬀord 38.0 g (65%) of
ethyl N-methylglycinate with b.p. 43–45 C (12 torr) and nD
(ref. 20) 1.4105. Literature data:27 b.p. 46 C (12 torr), nD (ref.
20) 1.4144.
Methanesulfonyl chloride (11.5 g, 0.10 mmol) was added
dropwise to a cooled solution of ethyl-N-methylglycinate (11.7 g,
0.10 mol) and triethylamine (10.1 g, 0.10 mol) in diethyl ether
(80 mL). The mixture was stirred at ambient temperature for 2
h, the precipitate formed was ltered oﬀ, washed with ether (15
mL), and the combined organic solutions were evaporated in
vacuum. The residue was distilled to aﬀord 13.7 g (70%) of
ethyl-N-mesyl-N-methylglycinate with b.p. 144–145 C (9 torr)
and m.p. 34–35 C. IR spectrum (KBr, n, cm1): 1750 (C]O),
1360 and 1160 (SO2).
1H NMR spectrum (CDCl3, d, ppm (J, Hz)):
1.25 (3H, t, 3J 7.3, CH2CH3); 2.77 (3H, s, CH3N); 2.87 (3H, s,
CH3S); 4.05 (2H, s, NCH2).
13C NMR spectrum (CDCl3, d, ppm):
8.9 (CH2CH3); 35.3 (CH3N); 38.1 (CH3S); 51.4 (NCC(O)); 55.5
(CH2CH3); 173.9 (C]O). Found, %: C 37.08; H 6.65; N 7.11.
C6H13NO4S. Calculated, %: C 36.91; H 6.71; N 7.17.
N-Mesyl-(S)-prolinamide (6a)
Ethyl ester of N0-mesyl-(S)-proline (6.6 g, 30 mmol) was stirred
with 50 mL of a 25% aqueous ammonia solution for 5 days at
ambient temperature. The precipitate formed was isolated by
ltration, dried in the open air and used without further puri-
cation. Yield 5.5 g (96%), m.p. 156–157 C (from EtOH),
[a]25D 101.3 (c 1.93, H2O). IR spectrum (KBr, n, cm1): 3449,
3170 (NH2); 1619 (NCO), 1321 and 1140 (SO2).
1H NMR spec-
trum (DMSO-d6, d, ppm (J, Hz)): 1.75–2.25 (4H, m, 3,4-CH2); 2.83
(3H, s, CH3); 3.25–3.47 (2H, m, 5-CH2); 3.96–4.09 (1H, m, 2-CH);
6.1 and 6.7 (2H, two broad s, NH2).
13C NMR spectrum (DMSO-
d6, d, ppm): 22.0 (Me); 26.0 (C-4); 32.3 (C-3); 50.7 (C-5); 63.5 (C-
2); 175.8 (C]O). Found, %: C 37.35; H 6.39; N 14.50.
C6H12N2O3S. Calculated, %: C 37.49; H 6.29; N 14.57.
Table 4 Prediction of therapeutic eﬀects and mechanisms of action (PASS Online) and LD50 values of acute rat toxicity (GUSAR Online)
a
ID
Top 5 predicted therapeutic eﬀects
with probability > 50%
Top 5 predicted mechanisms of
action with probability > 50%
Predicted LD50 values in mg kg
1,
type of administration, class of
toxicity
8a Not predicted Acetylcholine neuromuscular
blocking agent
IP – out of AD, 127, IV, 4 class, 904,
PO, 4 class, SC – out of AD
8b Not predicted Acetylcholine neuromuscular
blocking agent
IP – out of AD, 96, IV, 4 class, 1270,
PO, 4 class, SC – out of AD
8c Spasmolytic Acetylcholine neuromuscular
blocking agent, anaphylatoxin
receptor antagonist
IP – out of AD, 156, IV, 4 class, 453,
PO, 4 class, 250, SC, 4 class
9a Antianginal, multiple sclerosis
treatment, antiparkinsonian,
neurodegenerative diseases
treatment
Phosphatidylinositol 3-kinase
C2beta inhibitor, RANTES
antagonist, insulin growth factor
agonist, insulin like growth factor 1
agonist
IP – out of AD, 80, IV, 4 class, PO –
out of AD, 487, SC, 4 class
9b Antianginal, cardiovascular
analeptic, multiple sclerosis
treatment, cell adhesion molecule
inhibitor
Integrin alpha2 antagonist,
calmodulin antagonist, nicotinic
alpha4beta4 receptor agonist
IP – out of AD, 101, IV, 4 class, PO –
out of AD, SC – out of AD
9c Antianginal Anaphylatoxin receptor antagonist,
phospholipid-translocating ATPase
inhibitor, 2-haloacid dehalogenase
inhibitor,
glycosylphosphatidylinositol
phospholipase D inhibitor, NADPH
peroxidase inhibitor
IP – out of AD, 130, IV, 4 class, PO –
out of AD, 225, SC, 4 class
a IP – intraperitoneal route of administration; IV – intravenous route of administration; PO – oral route of administration; SC – subcutaneous route
of administration; out of AD – compound is out of applicability domain of QSAR models.
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N-Tosyl-(S)-prolinamide (6b)
Prepared similar to 6a. Yield 6.2 g (93%), m.p. 161–162 C (from
EtOH), [a]25D 134.6 (c 1.06, H2O). IR spectrum (KBr, n, cm1):
1643 (NCO), 1344, 1156 (SO2).
1H NMR spectrum (DMSO-d6, d,
ppm (J, Hz)): 1.31–1.83 (4H, m, 3,4-CH2); 2.43 (3H, s, CH3); 3.11–
3.22 and 3.35–3.55 (2H, m, 5-CH2); 3.91–4.01 (1H, m, 2-CH); 5.95
and 6.71 (2H, two broad s, NH2); 7.36 (2H, d,
3J¼ 8.3, H Ar); 7.72
(2H, d, 3J 8.3, H Ar). 13C NMR spectrum (DMSO-d6, d, ppm): 22.0
(Me); 25.7 (C-4); 31.8 (C-3); 50.9 (C-5); 63.7 (C-2); 129.2 (C-3,5 Ar);
131.4 (C-2,6 Ar); 135.4 (C-1 Ar); 145.8 (C-4 Ar); 175.5 (C]O).
Found, %: C 37.58, H 6.27, N 14.50. C6H12N2O3S. Calculated, %:
C 37.49, H 6.29, N 14.57.
N-Mesyl-N-methylglycinamide (6c)
Prepared similar to 6a. Yield 4.1 g (82%), m. p. 170–171 C
(EtOH). IR spectrum (KBr, n, cm1): 3315, 3170 (NH2); 1657
(NCO), 1320 and 1150 (SO2).
1H NMR spectrum (DMSO-d6, d,
ppm (J, Hz)): 2.79 (3H, s, CH3); 2.87 (3H, s, CH3S); 3.58 and 3.71
(2H, two s, NCH2); 5.5 and 6.1 (2H, two broad s, NH2).
13C NMR
spectrum (DMSO-d6, d, ppm): 34.3 (CH3N); 37.1 (CH3S); 50.9
(NCC(O)); 174.9 (C]O). Found, %: C 29.18, H 5.92, N 16.81.
C4H10N2O3S. Calculated, %: C 28.91, H 6.06, N 16.86.
2,2,6,6-Tetramethyl-4-[N-mesyl-(S)-prolinyl]-2,6-
disilamorpholine (8a)
Amixture of 6a (0.96 g, 5 mmol), hexamethyldisilazane (0.81 g, 5
mmol), chloro(chloromethyl)dimethylsilane (2.15 g, 15 mmol)
and toluene (10 mL) was reuxed for 4 h, then allowed to cool
down, and the precipitate formed was ltered out. The
remaining solution was evaporated in vacuum, the residue was
dissolved in chloroform (30 mL) and stirred with a solution of
NaHCO3 (0.84 g, 10 mmol) in water (10 mL) for 2 h. The organic
layer was separated, the aqueous layer was extracted with
chloroform (20 mL), and the combined organic solutions were
evaporated in vacuum. Recrystallisation of the residue from
heptane/benzene (3 : 1) mixture aﬀorded 1.32 g (75%) of
compound 8a with m.p. 121–124 C and [a]25D 55.0 (c 1.31,
CHCl3). Found, %: C 41.25, H 7.56, N 7.80, S 9.03. C12H26N2-
O4SSi2. Calculated, %: C 41.11, H 7.48, N 7.99, S 9.15. IR spec-
trum (KBr, n, cm1): 1631 s (C]O), 1325 s, 1148 s (SO2).
1H NMR
spectrum (CDCl3, d, ppm): 0.18, 0.19, 0.21 and 0.31 (four s, 12H,
2Si(CH3)2); 1.88–2.34 (m, 4H, C
3H2 and C
4H2 Pro); 2.7 and 3.42
(dd, 2H, NCH2Si,
3JHH 15.34 Hz); 2.83 (dd, 2H, NCH2Si,
3JHH
15.34 Hz); 3.01 (s, 3H, SCH3); 3.45–3.52 and 3.56–3.63 (two m,
2H, C5H2 Pro); 4.80–4.87 (m, 1H, C
2H Pro). 13C NMR spectrum
(CDCl3, d, ppm): –0.76O 0.00 (m, 2SiMe2); 24.65 (
4C Pro); 30.79
(3C Pro); 39.9 (SC); 38.1 and 40.29 (two s, NCH2Si); 47.54 (
5C
Pro); 58.92 (C2 Pro); 169.64 (C]O). 29Si NMR spectrum (CDCl3,
d, ppm): 8.0, 10.5.
2,2,6,6-Tetramethyl-4-[N-tosyl-(S)-prolinyl]-2,6-
disilamorpholine (8b)
Prepared similar to 8a from 1.34 g of 6b. Yield 1.66 g (78%) with
m. p. 110–112 C (from heptane–benzene, 10 : 1) and
[a]25D 2.92 (c 1.85, CHCl3). Found, %: C 50.51, H 7.24, N 6.62, S
7.45. C18H30N2O4SSi2. Calculated, %: C 50.67, H 7.09, N 6.57, S
7.52. IR spectrum (KBr, n, cm1): 1629 s (C]O), 1580 m (Ar),
1325 s, 1148 s (SO2).
1H NMR spectrum (CDCl3, d, ppm): 0.17,
0.21, 0.23 and 0.34 (four s, 12H, 2Si(CH3)2); 1.88–2.05 (m, 4H,
Table 5 Crystallographic data and reﬁnement parameters for the structures 8a, 8a0, 8c and 9a
8a 8a0 8c 9a
Molecular formula C12H26N2O4SSi2 C12H26N2O4SSi2 C10H24N2O4SSi2 C12H26F2N2O3SSi2
Formula weight 350.59 350.59 324.55 372.59
Crystal system Orthorhombic Monoclinic Monoclinic Orthorhombic
Space group P212121 P21 P21/n P212121
Flack parameter 0.027(18) 0.03(9) — 0.016(13)
Z 8 2 4 8
a, A˚ 9.6000(5) 7.436(4) 15.1089(9) 13.0441(9)
b, A˚ 14.2422(7) 9.474(6) 6.6275(4) 15.9282(11)
c, A˚ 27.0844(14) 14.125(9) 16.4442(10) 18.2980(13)
a,  90 90 90 90
b,  90 104.082(9) 98.7620(10) 90
g,  90 90 90 90
V, A˚3 3703.1(3) 965.2(10) 1627.41(17) 3801.8(5)
rcalc (g cm
3) 1.258 1.206 1.325 1.302
m, cm1 3.19 3.06 3.57 3.25
F(000) 1504 376 696 1584
2qmax,  61.03 60.22 60.06 61.06
Reections collected 50 072 10 584 30 094 65 941
Independent reections (Rint) 11 308 (0.0355) 5331 (0.00) 4740 (0.0311) 11 597 (0.0327)
Number of reections with I > 2s(I) 10 588 3228 3981 10 557
Parameters 389 195 178 411
R1 [I > 2s(I)] 0.0344 0.0579 0.0484 0.0266
wR2 (all independent reections) 0.0793 0.1168 0.1022 0.0698
GOF 1.071 1.000 1.034 1.084
rmin/rmax (e A˚
3) 0.556/0.323 0.873/0.494 0.565/0.358 0.381/0.197
75324 | RSC Adv., 2016, 6, 75315–75327 This journal is © The Royal Society of Chemistry 2016
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C3H2 and C
4H2 Pro); 2.42 (s, 3H, ArCH3); 2.95 and 3.14 (dd, 2H,
NCH2Si,
3JHH 15.0 Hz); 2.99 and 3.04 (dd, 2H, NCH2Si,
3JHH
15.95 Hz); 3.39–3.46 and 3.50–3.57 (two m, 2H, C5H2 Pro); 4.87–
4.92 (m, 1H, C2H Pro); 7.28 and 7.79 (two d, 4H, Ar, 3JHH 8 Hz).
13C NMR spectrum (CDCl3, d, ppm): –0.57 O 0.00 (m, 2SiMe2);
21.47 (Me); 24.75 (4C Pro); 30.89 (3C Pro); 37.96 and 40.41 (two s,
NCH2Si); 48.09 (
5C Pro); 57.60 (C2 Pro); 127.48 (C2 and C6 Ar),
129.30 (C3 and C5 Ar), 136.50 (C1 Ar), 143.04 (C4 Ar), 169.52 (C]
O). 29Si NMR spectrum (CDCl3, d, ppm): 7.9, 10.4.
2,2,6,6-Tetramethyl-4-(N-mesylsarcosinyl)-2,6-
disilamorpholine (8c)
Prepared similar to 8a from 0.83 g of 6c. Yield 1.3 g (80%) with
m.p. 151–153 C (from heptane–benzene, 7 : 1). Found, %: C
37.28, H 7.24, N 8.64, S 9.51. C10H24N2O4SSi2. Calculated, %: C
37.01, H 7.45, N 8.63, S 9.88. IR spectrum (KBr, n, cm1): 1628 s
(C]O), 1323 s, 1153 s (SO2).
1H NMR spectrum (CDCl3, d, ppm):
0.18 and 0.23 (two s, 12H, 2Si(CH3)2); 2.79 and 3.06 (two s, 4H,
NCH2Si); 2.98 (s, 3H, NCH3); 2.99 (s, 3H, SCH3); 4.13 (s, 2H,
NCH2).
13C NMR spectrum (CDCl3, d, ppm): –0.37 and 0.19
(two s, 2Si(CH3)2); 35.44 (NMe); 37.95 and 39.70 (two s, NCH2Si);
38.15 (SMe); 51.56 (NCC]O); 165.58 (C]O). 29Si NMR spec-
trum (CDCl3, d, ppm): 8.3, 10.4.
N0,N0-Bis(dimethyluorosilylmethyl)-N-mesyl-(S)-prolinamide
(9a)
Boron triuoride (0.36 g, 2.5 mmol) was added dropwise to
a solution of 8a (0.88 g, 2.5 mmol) in acetonitrile (5 mL). The
reaction mixture was reuxed for 2 h, then evaporated in
vacuum. The remaining oil was reuxed with benzene (15 mL),
the precipitate was ltered out, and the solution was evaporated
in vacuum. The residue was recrystallised from heptane to
aﬀord 0.76 g (82%) of 9a with m.p. 100–101 C. Found, %: C
34.61, H 6.88, N 7.86, S 8.92. C10H24F2N2O3SSi2. Calculated, %:
C 34.66, H 6.98, N 8.08, S 9.25. IR spectrum (KBr, n, cm1): 1610
s, 1505 w (C]O), 1319 s, 1134 s (SO2).
1H NMR spectrum
(CDCl3, d, ppm): 0.22 and 0.31 (two s, 6H, Si
V(CH3)2); 0.41 and
0.46 (dd, 6H, SiIV(CH3)2,
3JHF 7.67 Hz); 1.86–1.93, 2.03–2.18 and
2.28–2.36 (m, 4H, C3H2 and C
4H2 Pro); 2.44 and 2.59 (dd, 2H,
NCH2Si
V, 3JHH 15.74 Hz); 2.98 (s, 3H, SCH3); 3.00–3.05 and 3.25–
3.30 (two m, 2H, NCH2Si
IV); 3.44–3.5 and 3.58–3.63 (two m, 2H,
C5H2 Pro); 4.75–4.77 (m, 1H, C
2H Pro). 13C NMR spectrum
(CDCl3, d, ppm):1.9O1.7 (m, SiIVCH3); 1.1–1.7 (m, SiVCH3);
24.95 (C4 Pro); 30.93 (C3 Pro); 39.23 (SC); 41.1O 41.5 (m, CH2Si
V
and CH2Si
IV); 47.72 (C5 Pro); 56.59 (C2 Pro); 172.51 (C]O). 19F
NMR spectrum (CDCl3, d, ppm): 159.15; 121.88. 29Si NMR
spectrum (CDCl3, d, ppm): 15.5 (d, 1JSiF 252 Hz), 28.9 (d, 1JSiF
284 Hz). 29Si NMR CP/MAS spectrum (d, ppm): 37.2 (d, 1JSiF
880 Hz), 32.7 (d, 1JSiF 1024 Hz).
N0,N0-Bis(dimethyluorosilylmethyl)-N-tosyl-(S)-prolinamide
(9b)
Prepared similar to 9a from 1.1 g of 8b. Yield 0.9 g (80%) withm.
p. 87–88 C (from heptane). Found, %: C 48.23, H 6.80, N 6.15, S
7.20. C18H30F2N2O3SSi2. Calculated, %: C 48.18, H 6.74, N 6.24,
S 7.15. IR spectrum (KBr, n, cm1): 1602 s, 1515 w (C]O), 1336
s, 1151 s (SO2).
1H NMR spectrum (CDCl3, d, ppm): 0.18 and 0.22
(two s, 6H, SiV(CH3)2); 0.41–0.44 (m, 6H, Si
IV(CH3)2); 1.83–1.93
and 2.05–2.16 (two m, 4H, C3H2 and C
4H2 Pro); 2.43 and 2.51
(dd, 2H, NCH2Si
V, 3JHH 15.74 Hz); 2.45 (s, 3H, ArCH3); 3.04–3.08
and 3.52–3.59 (two m, 2H, NCH2Si
IV); 3.35–3.4 and 3.46–3.52
(two m, 2H, C5H2 Pro); 4.78–4.81 (m, 1H, C
2H Pro), 7.32 (d, 2H,
Ar, 3JHH 8.07 Hz), 7.75 (d, 2H, Ar,
3JHH 8.07 Hz).
13C NMR
spectrum (CDCl3, d, ppm): 1.92 O 1.78 (m, SiIVCH3); 1.20–
1.37 (m, SiVCH3); 21.46 (ArMe); 24.89 (C
4 Pro); 30.63 (C3 Pro);
41.27 (d, CH2Si
IV, 3JCF 16.69 Hz); 41.36–41.47 (m, CH2Si
V); 48.24
(C5 Pro); 55.45 (C2 Pro); 127.31 (C2 and C6 Ar), 129.64 (C3 and C5
Ar), 135.89 (C1 Ar), 143.74 (C4 Ar); 172.39 (C]O). 19F NMR
spectrum (CDCl3, d, ppm): 159.47; 119.31. 29Si NMR spec-
trum (CDCl3, d, ppm): 19.1 (d, 1JSiF 236 Hz), 28.1 (d, 1JSiF 276
Hz). 29Si NMR CP/MAS spectrum (d, ppm): 32.0 (d, 1JSiF 251
Hz), 30.7 (d, 1JSiF 292 Hz).
N0,N0-Bis(dimethyluorosilylmethyl)-N-mesylsarcosinamide
(9c)
Prepared similar to 9a from 0.80 g of 8c. Yield 0.73 g (85%) with
m. p. 135–136 C (from heptane). Found, %: C 34.61, H 6.88, N
7.86, S 8.92. C10H24F2N2O3SSi2. Calculated, %: C 34.66, H 6.98,
N 8.08, S 9.25. IR spectrum (KBr, n, cm1): 1610 s, 1505 w (C]
O), 1319 s, 1134 s (SO2).
1H NMR spectrum (CDCl3, d, ppm): 0.30
(two s, 6H, Si(CH3)2); 0.39–0.43 (m, 6H, Si
IV(CH3)2); 2.56 and
3.05 (two s, 4H, NCH2Si); 2.96 (s, 3H, NCH3); 2.98 (s, 3H, SCH3);
4.17 (s, 2H, NCH2).
13C NMR spectrum (CDCl3, d, ppm):1.8 (d,
SiMe2,
2JCF 14.5 Hz), 1.2 (s, SiMe2); 35.3 (NMe); 37.9 and 40.8
(two s, NCH2Si); 41.4 (SMe); 49.7 (NCC]O); 168.6 (C]O). NMR
19F spectrum (CDCl3, d, ppm): 159.15; 125.46. 29Si NMR
spectrum (CDCl3, d, ppm): 10.5 (d, 1JSiF 248 Hz), 29.2 (d, 1JSiF
287 Hz).
Single crystals suitable for X-ray diﬀraction analysis were
obtained by recrystallisation from: orthorhombic 8a—heptane/
benzene 3 : 1; monoclinic 8a0—ethanol; 8c—heptane/benzene
7 : 1; 9a—heptane. X-ray diﬀraction measurements were
carried out using Bruker Smart 1000 CCD and Bruker Smart
Apex II CCD diﬀractometers at 100 K. The frames were inte-
grated using SMART and APEX2 program packages.28 The
correction for absorption was made using SADABS program.29
The details of crystallographic data and experimental condi-
tions are given in Table 5.
The structures were solved by the direct method by XS
program30 and rened by full-matrix least-squares technique
against F2 in the anisotropic–isotropic approximation using XL
program.30 Atom H20 in s was located from the diﬀerence
Fourier maps and rened freely. All remaining hydrogen atoms
were placed in geometrically calculated positions and rened in
rigid body model (Uiso(H) ¼ 1.2Ueq(CH, CH2), Uiso(H) ¼
1.5Ueq(CH3)). The Flack parameter conrms (S)-conguration of
the proline fragment. Preparation of graphic materials was
performed using OLEX2 soware package.31 Crystallographic
data for the structural analysis of 8a, 8a0, 8c and 9a have been
deposited with the Cambridge Crystallographic Data Centre
(CCDC nos 1059570–1059573).
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 75315–75327 | 75325
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